Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vicks Sinex Vapospray recall

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble for the second time in seven months recalls a product in its Vicks Sinex line. In the most recent recall, announced June 24 for Vicks Sinex Vapospray 4-Hour Decongestant - sold before June 2009 as Sinex Nasal Spray or Ultra Fine Mist - P&G said the formulation may not meet the expiration dates on packages. The firm said packages marked with an expiration date prior to June 2013 should be discarded. A spokeswoman said routine testing found the problems, but the firm has not determined the cause. She added P&G has not determined the number of lots or units affected by the recall, but said the product accounts for less than 1.5 percent of Vicks products' U.S. sales. This recall follows the November 2009 recall of Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist after P&G found bacteria in a product made at its plant in Gross Gerau, Germany. ... Scope child-proof caps fail: Malfunctioning child-resistant caps "in a small percentage of bottles" lead to P&G's recall of 1-liter bottles of Scope Original Mint and Scope Peppermint mouthwash in the U.S. and Canada. The firm said June 25 a number 4 is embossed on the bottom of the affected bottles to the right of the recycling symbol. Though P&G said the recall is precautionary and the product in the affected bottles is safe for use, the firm will provide refund coupons
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS104258

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel